Clinical Trials Directory

Trials / Completed

CompletedNCT01468792

Hemodynamic Changes in Connective Tissue Disease

Status
Completed
Phase
Study type
Observational
Enrollment
85 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study serves the identification of early forms of pulmonary arterial hypertension (PAH) in connective tissue disease and the hemodynamic follow-up of the investigated patients. The basic hypothesis is that PAH may start with a remodeling of small pulmonary arteries, which leads to a stiffening of the vessels, indicated by the inability to vasodilatation and thus a disproportional increase in pulmonary pressure during exercise. Recent studies have shown that a proportion of such patients may develop manifest PAH within a few years. The early identification of these patients and the understanding of the natural course of the disease may improve prognosis. The aim of the present study is to investigate hemodynamic and clinical changes in patients with connective tissue disease in a time interval of 3-5 years with a focus on the development of pulmonary hypertension.

Conditions

Timeline

Start date
2011-09-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2011-11-09
Last updated
2014-02-19

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01468792. Inclusion in this directory is not an endorsement.

Hemodynamic Changes in Connective Tissue Disease (NCT01468792) · Clinical Trials Directory